Vision Point Advisory Group, LLC Amgen Inc Transaction History
Vision Point Advisory Group, LLC
- $473 Million
- Q3 2025
A detailed history of Vision Point Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 3,748 shares of AMGN stock, worth $1.13 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,748
Previous 3,501
7.06%
Holding current value
$1.13 Million
Previous $977,000
8.19%
% of portfolio
0.22%
Previous 0.23%
Shares
14 transactions
Others Institutions Holding AMGN
# of Institutions
3,276Shares Held
441MCall Options Held
6.15MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$16.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.84 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.69 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$5.08 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $161B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...